Regulatory
Product Development
Quality
Marketing
Topics
Blog
Library
QMS Toolkits
FDA Overview
Services
Regulatory
Product Development
Quality
Marketing
Topics
Resources
Blog
Library
QMS Toolkits
FDA Overview
Contact Us
Home
/
Library
/
De Novo Classification Order DEN240068: ArteraAI Prostate (FDA, Jul 2025)
FDA
De Novo Classification Order DEN240068: ArteraAI Prostate (FDA, Jul 2025)
FDA De Novo classification order for ArteraAI's AI-based prostate cancer prognostic software.
July 1, 2025
Published
FDA
Source
AI/ML SaMD
ai-ml-samd
FDA
fda
Topic
Open PDF
https://cdn.prod.website-files.com/5f10960649ee0832d2b92042/68b894124f359291bb1be587_DEN240068%20-%20ArteraAI%20-%20Classification%20Order.pdf
Back to library
